Scientists find that HIV drug attacks HPV virus

A team of researchers have concluded that the HIV drug lopinavir attacks the HPV virus that causes cervical cancer. The scientists say that the oral drug could be reconstituted as a cream that would help prevent surgery to remove early-stage cancer. They also note that the current vaccines being developed will not protect women who have already been exposed to the HPV virus. In the UK alone, some 50,000 women have surgery each year to remove the cancer.

- here's the BBC report on lopinavir

Suggested Articles

Merck’s TIGIT-blocking prospect and PD-1 med Keytruda shrank tumors in 29% of lung cancer patients who had never tried a checkpoint inhibitor.

Amunix reported that a single dose of its lead T-cell engager caused caused large HER2-positive tumors to shrink in mice.

The series C positions Lava to begin assessing the drugs in proof-of-concept clinical trials in solid tumors and hematological malignancies.